Drug giant Merck acquires Seattle biotech Immune Design for $300 million

The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 21, 2019 Category: Pharmaceuticals Authors: Casey Coombs Source Type: news